LOGO.png
Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update
13 nov. 2023 16h14 HE | Nemaura Medical, Inc
Loughborough, England, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
LOGO.png
Nemaura Medical Announces Fiscal Third Quarter 2022 Financial Results and Provides Business Update
14 févr. 2022 08h00 HE | Nemaura Medical, Inc
Loughborough, England, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Reports Financial Results and Provides Business Update for the First Fiscal Quarter Ended June 30, 2021
16 août 2021 08h30 HE | Nemaura Medical, Inc
Loughborough, England, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Appoints Samantha Sanders as Global Head of Digital Programs
15 avr. 2021 08h07 HE | Nemaura Medical, Inc
Loughborough, England, April 15, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical to Present at the H.C. Wainwright Global Life Sciences Conference
02 mars 2021 08h00 HE | Nemaura Medical, Inc
Loughborough, England, March 02, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Secures $20 Million Non-Dilutive Loan to Accelerate Business Growth
11 févr. 2021 08h45 HE | Nemaura Medical, Inc
Loughborough, England, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...